SYNLAB France

SYNLAB France provides medical biology and diagnostic laboratory services, performing a wide range of tests for patients, hospitals, and clinics. It operates medical laboratories that analyze biological samples to support clinical decision‑making and disease monitoring. The organization offers services in areas such as clinical chemistry, hematology, microbiology, immunology, and molecular biology. It serves both public and private healthcare providers across France.

While specific employee numbers or revenue are not disclosed in the provided sources, SYNLAB France is part of the broader Synlab Group, which operates numerous laboratories across Europe and serves a large patient base. The incident description notes that four of its laboratories were affected, indicating a multi‑site presence within the country. This suggests a notable footprint in the French diagnostic sector.

SYNLAB France specializes in medical biology and is accredited to meet national and international quality standards for laboratory testing. Its integration with hospital and clinic networks allows it to provide timely diagnostic information that supports patient care pathways. The organization emphasizes data security and compliance with health information regulations, as evidenced by its prompt response to the 2023 cybersecurity incident and cooperation with authorities.

SYNLAB France functions as the French subsidiary of the Synlab Group, a European laboratory services provider headquartered in Germany. As part of the group, it benefits from shared expertise, standardized processes, and centralized governance while maintaining local operational autonomy. Ownership details of the parent group are not specified in the available material.